Ad is loading...
Ad is loading...
GCVTX vs VIVIX
GCVTX vs VIVIX Comparison
Open Charts GCVTX vs VIVIX
Goldman Sachs Large Cp Val Insghts I
Price$26.98
Change-$0.15 (-0.55%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.70
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
GCVTX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
GCVTX vs. VIVIX commentary
Nov 18, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVTX is a StrongBuy and VIVIX is a StrongSell.
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. GCVTX (398M). VIVIX pays higher dividends than GCVTX: VIVIX (2.37) vs GCVTX (1.25). GCVTX was incepted earlier than VIVIX: GCVTX (17 years) vs VIVIX (26 years). GCVTX is a more actively managed with annual turnover of: 208.00 vs. VIVIX (10.00). GCVTX has a lower initial minimum investment than VIVIX: GCVTX (0) vs VIVIX (5000000). GCVTX (26.61) and VIVIX (25.54) have marching annual gain over last year. VIVIX return over 5 years is better than : 50.79 vs. GCVTX (31.37).
| GCVTX | VIVIX | GCVTX / VIVIX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 17 years | 26 years | - |
| Gain YTD | 21.232 | 17.922 | 118% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 398M | 184B | 0% |
| Annual Yield % from dividends | 1.25 | 2.37 | 53% |
| Returns for 1 year | 26.61 | 25.54 | 104% |
| Returns for 3 years | 2.13 | 21.57 | 10% |
| Returns for 5 years | 31.37 | 50.79 | 62% |
| Returns for 10 years | 77.18 | 110.50 | 70% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FLUEX | 28.90 | -0.06 | -0.21% |
| Fidelity Advisor Stk Selec Lg Cp Val C | |||
| VSFSX | 27.93 | -0.28 | -0.99% |
| Federated Hermes Clover Small Value R6 | |||
| LGLIX | 48.29 | -0.84 | -1.71% |
| Lord Abbett Growth Leaders I | |||
| RYHCX | 29.15 | -0.68 | -2.28% |
| Rydex Health Care C | |||
| DRYQX | 20.58 | -0.48 | -2.28% |
| BNY Mellon Research Growth Y | |||